Fifth Third Bancorp Rocket Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.96 - $16.64 $159 - $332	-20 Reduced 16.26%	103 $1,000
Q1 2022 Apr 19, 2022	BUY	$13.16 - $23.68 $987 - $1,776	75 Added 156.25%	123 $2,000
Q4 2021 Feb 01, 2022	BUY	$21.52 - $36.02 $193 - $324	9 Added 23.08%	48 $1,000
Q2 2021 Aug 06, 2021	BUY	$39.41 - $47.25 $472 - $567	12 Added 44.44%	39 $2,000
Q1 2021 May 07, 2021	BUY	$43.34 - $65.91 $476 - $725	11 Added 68.75%	27 $1,000
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $372 - $953	16 New	16 $1,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.